| Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm ER Zunder, R Finck, GK Behbehani, ED Amir, S Krishnaswamy, ... Nature protocols 10 (2), 316-333, 2015 | 502 | 2015 |
| Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia MY Kim, KR Yu, SS Kenderian, M Ruella, S Chen, TH Shin, AA Aljanahi, ... Cell 173 (6), 1439-1453. e19, 2018 | 395 | 2018 |
| Single‐cell mass cytometry adapted to measurements of the cell cycle GK Behbehani, SC Bendall, MR Clutter, WJ Fantl, GP Nolan Cytometry Part A 81 (7), 552-566, 2012 | 249 | 2012 |
| Association and regulation of the BLM helicase by the telomere proteins TRF1 and TRF2 K Lillard-Wetherell, A Machwe, GT Langland, KA Combs, GK Behbehani, ... Human molecular genetics 13 (17), 1919-1932, 2004 | 199 | 2004 |
| Transient partial permeabilization with saponin enables cellular barcoding prior to surface marker staining GK Behbehani, C Thom, ER Zunder, R Finck, B Gaudilliere, ... Cytometry Part A 85 (12), 1011-1019, 2014 | 121 | 2014 |
| Mass cytometric functional profiling of acute myeloid leukemia defines cell-cycle and immunophenotypic properties that correlate with known responses to therapy GK Behbehani, N Samusik, ZB Bjornson, WJ Fantl, BC Medeiros, ... Cancer discovery 5 (9), 988-1003, 2015 | 109 | 2015 |
| CD56 expression marks human group 2 innate lymphoid cell divergence from a shared NK cell and group 3 innate lymphoid cell developmental pathway L Chen, Y Youssef, C Robinson, GF Ernst, MY Carson, KA Young, ... Immunity 49 (3), 464-476. e4, 2018 | 104 | 2018 |
| Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia DAC Fisher, O Malkova, EK Engle, CA Miner, MC Fulbright, ... Leukemia 31 (9), 1962-1974, 2017 | 87 | 2017 |
| Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma S Khatua, LJN Cooper, DI Sandberg, L Ketonen, JM Johnson, ME Rytting, ... Neuro-oncology 22 (8), 1214-1225, 2020 | 61 | 2020 |
| BLM helicase facilitates RNA polymerase I-mediated ribosomal RNA transcription PM Grierson, K Lillard, GK Behbehani, KA Combs, S Bhattacharyya, ... Human molecular genetics 21 (5), 1172-1183, 2012 | 58 | 2012 |
| Decrease post-transplant relapse using donor-derived expanded NK-cells SO Ciurea, P Kongtim, D Soebbing, P Trikha, G Behbehani, G Rondon, ... Leukemia 36 (1), 155-164, 2022 | 54 | 2022 |
| An SNF2 factor involved in mammalian development and cellular proliferation EH Raabe, L Abdurrahman, G Behbehani, RJ Arceci Developmental dynamics: an official publication of the American Association …, 2001 | 54 | 2001 |
| Multi‐site reproducibility of a human immunophenotyping assay in whole blood and peripheral blood mononuclear cells preparations using CyTOF technology coupled with Maxpar … CB Bagwell, B Hunsberger, B Hill, D Herbert, C Bray, T Selvanantham, ... Cytometry Part B: Clinical Cytometry 98 (2), 146-160, 2020 | 48 | 2020 |
| The APC tumor suppressor inhibits DNA replication by directly binding to DNA via its carboxyl terminus J Qian, AA Sarnaik, TM Bonney, J Keirsey, KA Combs, K Steigerwald, ... Gastroenterology 135 (1), 152-162, 2008 | 48 | 2008 |
| The APC Tumor Suppressor Promotes Transcription-Independent Apoptosis In vitro K Steigerwald, GK Behbehani, KA Combs, MC Barton, J Groden Molecular cancer research 3 (2), 78-89, 2005 | 48 | 2005 |
| Pre-operative exercise therapy triggers anti-inflammatory trained immunity of Kupffer cells through metabolic reprogramming H Zhang, T Chen, J Ren, Y Xia, A Onuma, Y Wang, J He, J Wu, H Wang, ... Nature metabolism 3 (6), 843-858, 2021 | 47 | 2021 |
| Applications of mass cytometry in clinical medicine: the promise and perils of clinical CyTOF GK Behbehani Clinics in laboratory medicine 37 (4), 945-964, 2017 | 46 | 2017 |
| Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia D Papaioannou, C Shen, D Nicolet, B McNeil, M Bill, M Karunasiri, ... Proceedings of the National Academy of Sciences 114 (23), E4641-E4647, 2017 | 40 | 2017 |
| Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study B Bhatnagar, Q Zhao, AS Mims, S Vasu, GK Behbehani, K Larkin, ... Leukemia & lymphoma 61 (2), 387-396, 2020 | 38 | 2020 |
| Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML JY Jeon, Q Zhao, DR Buelow, M Phelps, AR Walker, AS Mims, S Vasu, ... Investigational new drugs 38, 340-349, 2020 | 34 | 2020 |
